S. Kanputhorn et al. / Tetrahedron 66 (2010) 7539e7543
7543
([MꢀCl]þ), 331.1339 (Mþ; M¼C19H22ClNO2); labs nm
(
e
)
302
calcd 296.1645 ([MþH]þ), 295.1572 (Mþ; M¼C19H21NO2); labs nm (
e)
(10,517), 376 (5568); lem nm (lex¼376 nm) 489.
F
¼0.08.
316 (12,139), 372(8925); lem nm (lex¼372 nm) 483. ¼0.09.
F
4.3.3. 8-Hydroxy-2,5-dimethyl-4-phenylpyrano[2,3,4-ij]isoquinolin-
4.4.3. 2,5-Dimethyl-4-phenylpyrano[2,3,4-ij]isoquinolin-8(4H)-one
(6). Yield (0.056 g, 65%). Mp 132 ꢂC (dec); 1H NMR
2.01 (s, 3H),
2.21 (s, 3H), 5.45 (s, 1H), 6.43 (d, J¼1.2 Hz,1H), 6.49 (d, J¼1.2 Hz 1H),
6.86 (s, 1H), 7.45e7.47 (m, 2H), 7.68e7.72 (m, 3H); 13C NMR
19.1,
4-ium chloride (3e). Yield (0.123 g, 76%). Mp 258 ꢂC (dec); 1H NMR
d
d
2.15 (s, 3H), 2.35 (s, 3H), 5.81 (s,1H), 6.99 (d, J¼1.6 Hz,1H,), 7.01 (d,
J¼1.6 Hz, 1H), 7.33 (s, 1H), 7.50e7.51 (m, 2H), 7.75e7.77 (m, 3H); 13C
d
NMR
d
19.3, 19.7, 98.3, 101.5, 104.8, 110.0, 116.0, 127.10, 127.10,
19.5, 96.6, 104.9, 106.3, 108.6, 114.1, 127.74, 127.74, 130.4, 130.62,
130.62, 135.8, 137.3, 140.3, 147.8, 156.5, 166.2, 178.4; ESI-MS m/z
290.1 ([MþH]þ); ESIHRMS obsd 290.1137 ([MþH]þ), calcd 290.1176
130.97, 130.97, 130.97, 136.8, 136.9, 142.8, 150.5, 156.4, 166.3, 169.1;
ESI-MS m/z 290.1 ([MꢀCl]þ); ESIHRMS obsd 290.1110 ([MꢀCl]þ),
calcd 290.1176 ([MꢀCl]þ), 325.0870 (Mþ; M¼C19H16ClNO2); labs nm
([MþH]þ), 289.1103 (Mþ; M¼C19H15NO2); labs nm (
e) 317 (13,350),
(e
) 304 (7803), 372 (5943); lem nm (lex¼372 nm) 482.
F
¼0.07.
372 (10,350); lem nm (lex¼372 nm) 484.
F
¼0.07.
4.3.4. 4-Benzyl-8-hydroxy-2,5-dimethylpyrano[2,3,4-ij]isoquinolin-
4.4.4. 4-Benzyl-2,5-dimethylpyrano[2,3,4-ij]isoquinolin-8(4H)-one
(7). Yield (0.079 g, 87%). Mp 192 ꢂC (dec); 1H NMR
2.27 (s, 3H),
4-ium chloride (3f). Yield (0.152 g, 89%). Mp 291 ꢂC (dec); 1H NMR
d
d
2.43 (s, 3H), 2.54 (s, 3H), 5.64 (s, 2H), 6.80 (s, 1H), 6.96 (d, J¼1.6 Hz,
2.37 (s, 3H), 5.38 (s, 2H), 6.31 (s, 1H), 6.38 (d, J¼2.0 Hz, 1H), 6.47 (d,
1H), 7.00 (d, J¼2.0 Hz,1H), 7.15 (d, J¼7.2 Hz, 2H), 7.32 (s, 1H), 7.36 (d,
J¼1.6 Hz, 1H), 6.82 (s, 1H), 7.10 (d, J¼7.6 Hz, 2H), 7.30e7.33 (m, 1H),
J¼7.2 Hz, 1H), 7.39e7.43 (m, 2H); 13C NMR
d
18.9, 19.4, 51.4, 97.6,
7.36e7.40 (m, 2H); 13C NMR
d 18.7, 19.2, 50.3, 95.9, 105.1, 106.9,
101.6, 104.6, 110.7, 117.2, 125.26, 125.26, 128.0, 129.13, 129.13, 133.3,
136.7, 143.1, 150.5, 156.2, 166.0, 169.4; ESI-MS m/z 304.1 ([MꢀCl]þ);
ESIHRMS obsd 304.1365 ([MꢀCl]þ), calcd 304.1332 ([MꢀCl]þ),
108.3, 115.2, 125.14, 125.14, 127.7, 128.99, 128.99, 134.3, 135.6, 140.7,
147.8, 156.1, 166.4, 178.3; ESI-MS m/z 304.1 ([MþH]þ); ESIHRMS
obsd 304.1365 ([MþH]þ), calcd 304.1332 ([MþH]þ), 303.1259 (Mþ;
339.1026 (Mþ; M¼C20H18ClNO2); labs nm (
e
) 304 (8713), 374
M¼C20H17NO2); labs nm (
e) 317 (14,361), 372 (10,412); lem nm
lex¼372 nm) 488. ¼0.09.
(6533); lem nm (lex¼374 nm) 486.
F
¼0.08.
(
F
Acknowledgements
4.4. A general procedure for synthesis of N-substituted
cassiarin derivatives 4e7
We are thankful to Science and Technology Innovation Support
Grant, Faculty of Science, Chulalongkorn University for partial
financial support in this research.
To
a solution of N-substituted cassiarin A chloride 3cef
(0.30 mmol) in water (5.0 mL), was added triethylamine (0.061 g,
0.60 mmol). The mixture was stirred at room temperature for
5 min. The resulting solution was then extracted with chloroform
(15 mLꢁ4) or, in the case of 7, the resulting solid was filter off. For
4e6, the combined chloroform extracts were concentrated under
reduced pressure until the volume of organic extract was reduced
to 1.0 mL. The crude extract was kept at room temperature until the
yellow precipitate was obtained. The solid product was filtered off
and then dried under vacuum to give the N-substituted cassiarin B
derivative 4e7.
Supplementary data
Spectral data, including 1H NMR, 13C NMR, and high resolu-
tion mass spectra for new compounds. Supplementary data as-
sociated with this article can be found in online version at
InChIKeys of the most important compounds described in this
article.
References and notes
4.4.1. 4-Butyl-2,5-dimethylpyrano[2,3,4-ij]isoquinolin-8-(4H)-one
(4). Yield (0.054 g, 67%). Mp 167 ꢂC (dec); 1H NMR
d 1.02 (t,
1. Singh, V.; Singh, J.; Sharma, J. P. Phytochemistry 1992, 31, 2176e2177.
2. Koyama, J.; Morita, I.; Tagahara, K.; Aqil, M. Phytochemistry 2001, 56, 849e851.
3. El-Sayyad, S. M.; Ross, S. A.; Sayed, H. M. J. Nat. Prod. 1984, 47, 708e719.
4. Arora, S.; Deymann, H.; Tiwari, R. D.; Winterfeldt, E. Tetrahedron 1971, 27,
981e984.
J¼7.4 Hz, 3H), 1.43e1.53 (m, 2H), 1.61e1.68 (m, 2H), 2.35 (s, 3H),
2.41 (s, 3H), 3.96 (t, J¼8.2 Hz, 2H), 6.21 (s, 1H), 6.33 (s, 1H), 6.34 (s,
1H), 6.63 (s, 1H); 13C NMR
d 12.6, 18.7, 19.2, 19.2, 30.2, 47.2, 95.6,
104.9, 106.9, 107.7, 115.2, 135.4, 140.1, 146.6, 155.7, 165.9, 177.7; ESI-
5. Biwas, K. M.; Mallik, H. Phytochemistry 1986, 25, 1727e1730.
6. Hassanali, A.; King, T. J.; Wallwork, S. C. J. Chem. Soc., Chem. Commun. 1969, 678.
7. Morita, H.; Oshimi, S.; Hirasawa, Y.; Koyama, K.; Honda, T.; Ekasari, W.; In-
drayanto, G.; Zaini, N. C. Org. Lett. 2007, 9, 3691e3693.
8. Rudyanto, M.; Tomizawa, Y.; Morita, H.; Honda, T. Org. Lett. 2008, 10,
1921e1922.
MS m/z 270.2 ([MþH]þ); ESIHRMS obsd 270.1538 ([MþH]þ), calcd
270.1489 ([MþH]þ), 269.1416 (Mþ; M¼C17H19NO2); labs nm (
e) 316
(13,193), 369 (9016); lem nm (lex¼369 nm) 484.
F
¼0.09.
9. Yao, Y.-S.; Yao, Z.-J. J. Org. Chem. 2008, 73, 5221e5225.
10. Morita, H.; Tomizawa, Y.; Deguchi, J.; Ishikawa, T.; Arai, H.; Zaima, K.; Hosoya,
T.; Hirasawa, Y.; Matsumoto, T.; Kamata, K.; Ekasari, W.; Widyawaruyanti, A.;
Wahyuni, T. S.; Zaini, N. C.; Honda, T. Bioorg. Med. Chem. 2009, 17, 8234e8242.
11. Bycroft, B. W.; Hassaniali-Walji, A.; Johnson, A. W.; King, T. J. J. Chem. Soc. C 1970,
12, 1686e1689.
12. Tolkunov, S. V.; Kryuchkov, M. A.; Tolkunov, V. S.; Dulenko, V. I. Chem. Heter-
ocycl. Compd. 2004, 40, 1082e1086.
13. Kibalny, A. V.; Afonin, A. A.; Dulenko, V. I. Chem. Heterocycl. Compd. 2004, 40,
1131e1136.
4.4.2. 4-Cyclohexyl-2,5-dimethylpyrano[2,3,4-ij]isoquinolin-8(4H)-
one (5). Yield (0.059 g, 67%). Mp 136 ꢂC (dec); 1H NMR (CD3OD/
CDCl3 (1:4))
d 1.21e1.31 (m, 1H), 1.39e1.48 (m, 2H), 1.80 (d,
J¼12.8 Hz, 1H), 1.90 (d, J¼12.4 Hz, 2H), 2.00 (d, J¼13.2 Hz, 2H),
2.22e2.26 (m, 2H), 2.43 (d, J¼5.6 Hz, 3H), 2.43 (s, 3H), 4.32e4.39 (m,
1H), 6.32 (s, 1H), 6.39 (s, 1H), 6.49 (s, 1H), 6.63 (s, 1H); 13C NMR
(CD3OD/CDCl3 (1:4)) d 20.8, 21.4, 24.7, 26.14, 26.14, 29.34, 29.34, 61.5,
97.7, 106.2, 108.5, 108.7, 116.9, 135.0, 139.4, 146.9, 155.9, 163.6, 178.4;
14. Deachapunya, C.; Poonyachoti, S.; Thongsaard, W.; Krishanamra, N. J. Pharma-
col. Exp. Ther. 2005, 314, 732e737.
ESI-MS m/z 296.2 ([MþH]þ); ESIHRMS obsd 296.1676 ([MþH]þ),